Literature DB >> 16401528

Complementary and alternative medicine use in lung cancer patients in eight European countries.

Alexander Molassiotis1, Vassiliki Panteli, Elisabeth Patiraki, Gulten Ozden, Nurgun Platin, Elin Madsen, Maria Browall, Paz Fernandez-Ortega, Dorit Pud, Anita Margulies.   

Abstract

This paper presents findings from a cross-sectional survey about the use of complementary and alternative medicine (CAM) in patients with lung cancer, forming part of a larger study. Data from 111 lung cancer patients in 8 countries in Europe were collected through a descriptive 27-item questionnaire. The data suggest that 23.6% of the lung cancer patients used CAM after the diagnosis with cancer. The most popular CAM modalities were herbal medicine (48.1%), medicinal teas (11.5%), homeopathy (11.5%), use of animal extracts (11.5%) and spiritual therapies (11.5%). Herbal use increased by three times after the diagnosis of cancer. Patients seemed quite satisfied with the CAM used. They were also spending on average about 142 Euros monthly on CAM therapies or remedies. The most common motivation to use CAM was to increase the body's ability to fight the cancer. Main sources of information about CAM were friends and family. As CAM is increasingly used by patients with lung cancer, it is important to be able to assist patients make an appropriate decision by discussing the issue of CAM openly, providing reassurance and communicating safe and appropriate information to patients.

Entities:  

Mesh:

Year:  2005        PMID: 16401528     DOI: 10.1016/j.ctcp.2005.09.007

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  23 in total

1.  Reported effects of non-traditional treatments and complementary and alternative medicine by retinitis pigmentosa patients.

Authors:  Ava K Kiser; Gislin Dagnelie
Journal:  Clin Exp Optom       Date:  2008-03       Impact factor: 2.742

Review 2.  Great expectations: what do patients using complementary and alternative medicine hope for?

Authors:  E Ernst; S K Hung
Journal:  Patient       Date:  2011       Impact factor: 3.883

3.  Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey.

Authors:  Joshua Bauml; Corey J Langer; Tracey Evans; Sheila N Garland; Krupali Desai; Jun J Mao
Journal:  Support Care Cancer       Date:  2014-04-09       Impact factor: 3.603

4.  An assessment of the impact of herb-drug combinations used by cancer patients.

Authors:  Saud M Alsanad; Rachel L Howard; Elizabeth M Williamson
Journal:  BMC Complement Altern Med       Date:  2016-10-18       Impact factor: 3.659

5.  Complementary and alternative medicine use among patients with thoracic malignancies.

Authors:  Rashmi S Bismark; Hongbin Chen; Grace K Dy; Elizabeth A Gage-Bouchard; Martin C Mahoney
Journal:  Support Care Cancer       Date:  2014-02-21       Impact factor: 3.603

6.  Colorectal cancer in Turkey: current situation and challenges for the future.

Authors:  Mehtap Tatar; Fahreddin Tatar
Journal:  Eur J Health Econ       Date:  2010-01

7.  Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.

Authors:  Daniel Merenstein; Yang Yang; Michael F Schneider; Lakshmi Goparaju; Kathleen Weber; Anjali Sharma; Alexandra M Levine; Gerald B Sharp; Monica Gandhi; Chenglong Liu
Journal:  Altern Ther Health Med       Date:  2008 Sep-Oct       Impact factor: 1.305

Review 8.  Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Authors:  Paul Posadzki; Leala K Watson; Amani Alotaibi; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

9.  The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study.

Authors:  G Kasymjanova; M Grossman; T Tran; R T Jagoe; V Cohen; C Pepe; D Small; J Agulnik
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

10.  Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Authors:  Nandini Bhattacharjee; Surajit Pathak; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.